| Dr Yun Pan, DPM | |
|
109 Wimbledon Sq Ste F, Chesapeake, VA 23320-4945 | |
| (757) 979-4028 | |
| Not Available |
| Full Name | Dr Yun Pan |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 6 Years |
| Location | 109 Wimbledon Sq Ste F, Chesapeake, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457845562 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | PO4127 (Florida) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 0103301316 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Virginia Foot And Ankle Pllc | 2567863087 | 2 |
News Archive
Cancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the body; the tumors actually put myeloid cells to work helping them grow and metastasize (spread).
Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers.
› Verified 7 days ago
| Provider Name | Senior Well Pod Of Virginia, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750854881 PECOS PAC ID: 7618301730 Enrollment ID: O20191226001385 |
News Archive
Cancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the body; the tumors actually put myeloid cells to work helping them grow and metastasize (spread).
Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers.
› Verified 7 days ago
| Provider Name | Eastern Virginia Foot And Ankle Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1528650744 PECOS PAC ID: 2567863087 Enrollment ID: O20210622001166 |
News Archive
Cancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the body; the tumors actually put myeloid cells to work helping them grow and metastasize (spread).
Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers.
› Verified 7 days ago
| Provider Name | Pedirite Medical Va Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851962229 PECOS PAC ID: 3072916907 Enrollment ID: O20210729000781 |
News Archive
Cancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the body; the tumors actually put myeloid cells to work helping them grow and metastasize (spread).
Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yun Pan, DPM 109 Wimbledon Sq Ste F, Chesapeake, VA 23320-4945 Ph: (757) 698-4177 | Dr Yun Pan, DPM 109 Wimbledon Sq Ste F, Chesapeake, VA 23320-4945 Ph: (757) 979-4028 |
News Archive
Cancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the body; the tumors actually put myeloid cells to work helping them grow and metastasize (spread).
Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers.
› Verified 7 days ago
Family Foot And Ankle Care Podiatrist Medicare: Medicare Enrolled Practice Location: 801 Volvo Pkwy, Suite 130, Chesapeake, VA 23320 Phone: 757-547-3668 Fax: 757-547-4335 | |
Diaz Foot & Ankle Center Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 612 Kingsborough Sq, Suite 202, Chesapeake, VA 23320 Phone: 757-673-8562 Fax: 757-673-8174 | |
Family Foot And Ankle Care Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 801 Volvo Pkwy, #130, Chesapeake, VA 23320 Phone: 757-547-3668 Fax: 757-547-4335 | |
Johnnie Nine Toes Podiatrist Medicare: Medicare Enrolled Practice Location: 1416 Shenandoah Pkwy, Chesapeake, VA 23320 Phone: 757-418-4556 Fax: 757-549-2004 | |
Dr. Marc Joel Fink, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 801 Volvo Pkwy, Suite 130, Chesapeake, VA 23320 Phone: 757-547-3668 Fax: 757-547-4335 | |
John G Piacenti, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1416 Shenandoah Pkwy, Chesapeake, VA 23320 Phone: 757-549-7945 Fax: 757-549-2004 | |
Kevin L Craney, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 369 Johnstown Rd, Chesapeake, VA 23322 Phone: 757-547-0123 Fax: 757-547-2412 |